ESCMID Postgraduate Education Course: Diagnosis and Management of Fungal Infections Both in the West and the East.
For all presentations in session 1-5 see below:
New Mexico VA Health Care System and University of New Mexico are seeking an Academic Infectious Diseases Specialist, open rank. The ideal candidate is an accomplished physician¬-investigator, including NIH or VA funding, and strong productivity as demonstrated by a track record of grants and peer-reviewed publications. Research focus in any aspect of fungal pathogenesis, antifungal drug discovery, clinical investigation of IFI's, or any broad topic related to IFI's is of particular interest. Lab space and startup package will be offered to the qualified candidate.
The Fungal Infection Trust has supported individuals and teams working on fungal disease for 24 years and provided over £3.5 million in funding. It supports The Aspergillus Website and LIFE initiative. Partly to raise awareness and partly for fundraising, it was awarded a charity place in the London marathon this year. Dr Jenny Long is an ENT trainee and running for the FIT, in a stunning hat! Please support her.
Jenny’s page: http://www.fit.care/
The new website of the Société Française de Mycologie Médicale (SFMM) which is now in French and English, is online.
on http://sfmm-mycologie-medicale.com you can find all news related to the society, particularly the agenda and the journal.
On March 6, 2014 the FDA approved isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis.
Here you can find the FDA press release
While the aspergillosis indication is based on a large, well-designed randomized clinical trial, the mucormycosis indication is based single arm study results compared to literature data and a comparison with results from the ECMM FungiScope registry. For ECMM this is a unprecedented success in this area.
Oliver A. Cornely
President of the ECMM
It is a great pleasure to invite you to the Post-Graduate Training Course “Paediatric Mycology” organized by European Paediatric Mycology Network (EPMyN). The EPMyN has been launched in 2014 to create a European platform for research and education in paediatric mycology with the ultimate goal to increase our understanding of invasive fungal infections in children and neonates and to improve the outcome.
Training / Workshop “Diagnosis of fungal infections – from patient sample to an mycologist`s opinion”
13 March, 2015, Hotel Crowne Plaza, Belgrade, Serbia
Chair: prof. dr Valentina Arsić Arsenijević
Organizer: Serbian Society of Medical Mycology
As you may be aware, the 19th ISHAM Congress will be held in Melbourne, Australia from the 4th - 8th May 2015. Further information about the congress can be found at: http://www.isham2015.com.au/
ISHAM 2015 NEWS!
Take advantage of the low Australian Dollar at the moment!
• Abstract submissions for ISHAM 2015 will close 15th February 2015!
Final deadline for abstract submissions for proffered oral presentations is 15th February 2015. Abstracts for proffered oral presentations will not be accepted after this deadline.
On January 22, 2015 the Anti-Infective Drug Advisory Committee (AIDAC) gave a positive opinion on isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis. The hearing at FDA Headquarters in Washington DC can be accessed online through the following links.
January 22, 2015, Meeting of the Anti-Infective Drugs Advisory
Committee (AIDAC) - Webcast Recording
Please check the below PDF to see the agenda of this GAFFI / BVGH meeting on 22 February 2015, in Seattle, USA